Loading...
Docoh

Caribou Biosciences (CRBU)

Caribou is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying the company’s proprietary chRDNA technology toward the development of next-generation, genome-edited cell therapies. The company is developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for the treatment of both hematologic malignancies and solid tumors against cell surface targets for which autologous CAR-T cell therapeutics have previously demonstrated clinical proof of concept, as well as additional emerging targets.

Company profile

Ticker
CRBU
Exchange
Employees
Incorporated
Location
Fiscal year end
SEC CIK
Subsidiaries
Antler Holdco, LLC • Arboreal Holdco, LLC • Biloba Holdco, LLC • Microbe Holdco, LLC ...
IRS number
453728228

CRBU stock data

Analyst ratings and price targets

Last 3 months

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

8 Aug 22
16 Aug 22
31 Dec 22
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 112.19M 112.19M 112.19M 112.19M 112.19M
Cash burn (monthly) 11.83M 1.45M 9.48M 7.56M 1.81M
Cash used (since last report) 18.56M 2.27M 14.87M 11.85M 2.83M
Cash remaining 93.63M 109.92M 97.32M 100.34M 109.36M
Runway (months of cash) 7.9 75.9 10.3 13.3 60.5

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
18 May 22 Johnson David Lee Option to purchase Common Stock Common Stock Grant Acquire A No No 9.12 44,000 401.28K 44,000
13 May 22 Steven Kanner Common Stock Option exercise Acquire M No No 2.69 6,114 16.45K 302,059
13 May 22 Steven Kanner Common Stock Option exercise Acquire M No No 1.81 68,306 123.63K 295,945
13 May 22 Steven Kanner Option to purchase Common Stock Common Stock Option exercise Dispose M No No 2.69 6,114 16.45K 116,849
13 May 22 Steven Kanner Option to purchase Common Stock Common Stock Option exercise Dispose M No No 1.81 68,306 123.63K 3,534
9 May 22 Rachel E. Haurwitz Common Stock Option exercise Acquire M No No 2.96 10,000 29.6K 20,000
9 May 22 Rachel E. Haurwitz Option to purchase Common Stock Common Stock Option exercise Dispose M No No 2.96 10,000 29.6K 116,350
5 May 22 Ryan Fischesser Common Stock Option exercise Acquire M No No 4.11 1,138 4.68K 115,518
5 May 22 Ryan Fischesser Common Stock Option exercise Acquire M No No 2.69 1,136 3.06K 114,380
5 May 22 Ryan Fischesser Option to purchase Common Stock Common Stock Option exercise Dispose M No No 4.11 1,138 4.68K 18,176
65.8% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 104 93 +11.8%
Opened positions 23 26 -11.5%
Closed positions 12 22 -45.5%
Increased positions 43 32 +34.4%
Reduced positions 18 11 +63.6%
13F shares Current Prev Q Change
Total value 407.4M 505.82M -19.5%
Total shares 40.01M 33.64M +19.0%
Total puts 12.1K 39.9K -69.7%
Total calls 38.2K 54.9K -30.4%
Total put/call ratio 0.3 0.7 -56.4%
Largest owners Shares Value Change
Partner Fund Management 4.37M $40.12M +6.8%
Rachel E. Haurwitz 3.35M $37.21M NEW
BLK Blackrock 3.32M $30.47M +88.3%
Avidity Partners Management 2.82M $25.88M +5.4%
Pictet Asset Management 2.68M $24.64M +40.1%
Farallon Capital Management 2.66M $24.39M -10.3%
Farallon Capital Partners 2.58M $41.11M 0.0%
FMR 2.01M $18.48M -39.4%
Vanguard 2M $18.38M +118.9%
Alkeon Capital Management 1.22M $11.23M -1.9%
Largest transactions Shares Bought/sold Change
Rachel E. Haurwitz 3.35M +3.35M NEW
BLK Blackrock 3.32M +1.56M +88.3%
FMR 2.01M -1.31M -39.4%
Vanguard 2M +1.09M +118.9%
JHG Janus Henderson 136.8K -1.04M -88.3%
Pictet Asset Management 2.68M +768.12K +40.1%
Coatue Management 0 -557.67K EXIT
JPM JPMorgan Chase & Co. 515.76K +497.69K +2754.9%
CloudAlpha Capital Management Limited/Hong Kong 0 -415K EXIT
STT State Street 743.02K +330.07K +79.9%

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: cease, cohort, inflationary, national, political, retirement, Shorter
Removed: announced, closing, converted, expenditure